[HTML][HTML] STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts
ML Ibba, G Ciccone, D Rotoli, G Coppola… - … Therapy-Nucleic Acids, 2023 - cell.com
The identification of new effective therapeutic options for non-small-cell lung cancer
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
[HTML][HTML] STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts
ML Ibba, G Ciccone, D Rotoli, G Coppola… - Molecular Therapy …, 2023 - ncbi.nlm.nih.gov
The identification of new effective therapeutic options for non-small-cell lung cancer
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
[HTML][HTML] STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts
ML Ibba, G Ciccone, D Rotoli, G Coppola… - … Therapy-Nucleic Acids, 2023 - Elsevier
The identification of new effective therapeutic options for non-small-cell lung cancer
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts
ML Ibba, G Ciccone, D Rotoli… - Molecular therapy …, 2023 - pubmed.ncbi.nlm.nih.gov
The identification of new effective therapeutic options for non-small-cell lung cancer
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts.
ML Ibba, G Ciccone, D Rotoli, G Coppola… - Molecular therapy …, 2023 - europepmc.org
The identification of new effective therapeutic options for non-small-cell lung cancer
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts
ML Ibba, G Ciccone, D Rotoli, G Coppola… - MOLECULAR …, 2023 - iris.unicampania.it
The identification of new effective therapeutic options for non-small-cell lung cancer
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts.
ML Ibba, G Ciccone, D Rotoli, G Coppola… - Molecular therapy …, 2023 - europepmc.org
The identification of new effective therapeutic options for non-small-cell lung cancer
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …
(NSCLC) represents a crucial challenge in oncology. Recent studies indicate that cancer …